Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 47.74
+1.19 (2.56%)
Apr 29, 2026, 3:00 PM CST
Cathay Biotech Revenue
In the year 2025, Cathay Biotech had annual revenue of 3.30B CNY with 11.40% growth. Cathay Biotech had revenue of 750.01M in the quarter ending December 31, 2025, with 0.97% growth.
Revenue
3.30B
Revenue Growth
+11.40%
P/S Ratio
10.18
Revenue / Employee
1.90M
Employees
1,764
Market Cap
33.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.30B | 337.14M | 11.40% |
| Dec 31, 2024 | 2.96B | 843.74M | 39.91% |
| Dec 31, 2023 | 2.11B | -326.93M | -13.39% |
| Dec 31, 2022 | 2.44B | 77.62M | 3.28% |
| Dec 31, 2021 | 2.36B | 866.29M | 57.86% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sichuan Em Technology | 5.49B |
| Inner Mongolia Berun Chemical Company | 11.92B |
| Levima Advanced Materials | 7.04B |
| Sichuan New Energy Power Company | 3.60B |
| Jinan Shengquan Group Share Holding | 11.15B |
| Jiangsu Boqian New Materials Stock | 1.15B |
| Do-Fluoride New Materials | 10.55B |
| Zhejiang Sanmei Chemical Industry | 5.43B |